Cargando…

Comment on “Perineural Invasion In Pancreatic Ductal Adenocarcinoma—What Can We Learn From The Past?’’

Detalles Bibliográficos
Autor principal:	Shen, Xiaofei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health, Inc. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455323/ https://www.ncbi.nlm.nih.gov/pubmed/37636548 http://dx.doi.org/10.1097/AS9.0000000000000062

Ejemplares similares

Molecular markers associated with perineural invasion in pancreatic ductal adenocarcinoma
por: Zhang, Junfeng, et al.
Publicado: (2020)

Cellular and molecular mechanisms of perineural invasion of pancreatic ductal adenocarcinoma
por: Li, Jingbo, et al.
Publicado: (2021)

Perineural invasion detection in pancreatic ductal adenocarcinoma using artificial intelligence
por: Borsekofsky, Sarah, et al.
Publicado: (2023)

Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies?
por: Felsenstein, Matthäus, et al.
Publicado: (2022)

Perineural Invasion in Pancreatic Ductal Adenocarcinoma: From Molecules towards Drugs of Clinical Relevance
por: Selvaggi, Federico, et al.
Publicado: (2022)

The Key Genes for Perineural Invasion in Pancreatic Ductal Adenocarcinoma Identified With Monte-Carlo Feature Selection Method
por: Zhu, Jin-Hui, et al.
Publicado: (2020)

Relationship between cachexia and perineural invasion in pancreatic adenocarcinoma
por: Petrusel, Livia, et al.
Publicado: (2019)

Comment on: “Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma”
por: Zheng, Yangyang, et al.
Publicado: (2023)

Perineural Invasion and TAMs in Pancreatic Ductal Adenocarcinomas: Review of the Original Pathology Reports Using Immunohistochemical Enhancement and Relationships with Clinicopathological Features
por: Zeng, Linjuan, et al.
Publicado: (2014)

Can we predict long-term survival in resectable pancreatic ductal adenocarcinoma?
por: Gall, Tamara M.H., et al.
Publicado: (2019)

A Novel Role of Interleukin 13 Receptor alpha2 in Perineural Invasion and its Association with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma †
por: Fujisawa, Toshio, et al.
Publicado: (2020)

DIPG in Children – What Can We Learn from the Past?
por: Vanan, Magimairajan Issai, et al.
Publicado: (2015)

Association of diabetes and perineural invasion in pancreatic cancer
por: Sahin, Ibrahim Halil, et al.
Publicado: (2012)

COVID‐19 and tourism: What can we learn from the past?
por: Aronica, Martina, et al.
Publicado: (2021)

Ductal Carcinoma In Situ: What Can We Learn from Clinical Trials?
por: Fortunato, Lucio, et al.
Publicado: (2012)

COVID-19 and Digestive System Involvement: Can We Learn from the Past
por: Jadali, Zohreh
Publicado: (2021)

Immune therapies in pancreatic ductal adenocarcinoma: Where are we now?
por: Hilmi, Marc, et al.
Publicado: (2018)

Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going
por: Coppola, Alessandro, et al.
Publicado: (2023)

Perineural Invasion and Associated Pain Transmission in Pancreatic Cancer
por: Wang, Jialun, et al.
Publicado: (2021)

Interobserver reproducibility of perineural invasion of prostatic adenocarcinoma in needle biopsies
por: Egevad, Lars, et al.
Publicado: (2021)

Pancreatic ductal adenocarcinoma in colonic wall: metastatic disease or cancerized pancreatic ectopic tissue?
por: Gallo, Graziana, et al.
Publicado: (2020)

Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma: Where Do We Go?
por: Wang, Chenqi, et al.
Publicado: (2022)

Correction: Felsenstein M. et al. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? J. Clin. Med. 2022, 11, 2367
por: Felsenstein, Matthäus, et al.
Publicado: (2023)

TRPM2 promotes the proliferation and invasion of pancreatic ductal adenocarcinoma
por: Lin, Rui, et al.
Publicado: (2018)

ADAM9 contributes to vascular invasion in pancreatic ductal adenocarcinoma
por: Oria, Victor O., et al.
Publicado: (2019)

Perineural invasion in pancreatic cancer: proteomic analysis and in vitro modelling
por: Alrawashdeh, Wasfi, et al.
Publicado: (2019)

Porocarcinoma with perineural invasion
por: Maguire, Ciara A., et al.
Publicado: (2015)

A Case of Pancreatic Ductal Adenocarcinoma Arising From Atypical Flat Lesions
por: Franklin, Oskar, et al.
Publicado: (2020)

Perineural invasion and perineural spread in periocular squamous cell carcinoma
por: Tong, Jessica Y., et al.
Publicado: (2022)

Letter to the editor: What we can learn from health transformation plan
por: Joulaei, Hassan, et al.
Publicado: (2019)

The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma
por: Sakaguchi, Tatsuma, et al.
Publicado: (2020)

Nodal Enhances Perineural Invasion in Pancreatic Cancer by Promoting Tumor-Nerve Convergence
por: Shen, Sugang, et al.
Publicado: (2022)

Fecal elastase, an assay for exocrine pancreatic insufficiency, has clinical utility in patients with pancreatic ductal adenocarcinoma
por: Gong, Jun, et al.
Publicado: (2020)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Syndecans and Pancreatic Ductal Adenocarcinoma
por: Betriu, Nausika, et al.
Publicado: (2021)

Models of pancreatic ductal adenocarcinoma
por: Dennaoui, Rayane, et al.
Publicado: (2021)

The Effects of Radiotherapy on Pancreatic Ductal Adenocarcinoma in Patients with Liver Metastases
por: Wu, Linxia, et al.
Publicado: (2022)

Basal Cell Carcinoma Perineural Invasion and Suggestive Signs of Perineural Invasion—Findings and Perspectives
por: Niculet, Elena, et al.
Publicado: (2023)

SLPI knockdown induced pancreatic ductal adenocarcinoma cells proliferation and invasion
por: Zhang, Wei, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_dm1nrii8dmcedk9kjcrq64kglf